XTX Topco Ltd Acquires Shares of 4,767 CME Group Inc. (NASDAQ:CME)

XTX Topco Ltd bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 4,767 shares of the financial services provider’s stock, valued at approximately $937,000.

A number of other institutional investors have also made changes to their positions in CME. Gold Investment Management Ltd. acquired a new stake in CME Group during the 4th quarter valued at $26,000. Salomon & Ludwin LLC acquired a new stake in shares of CME Group during the 1st quarter worth about $28,000. Y.D. More Investments Ltd bought a new stake in shares of CME Group during the 2nd quarter worth about $36,000. Rise Advisors LLC acquired a new position in CME Group in the 1st quarter valued at about $41,000. Finally, McClarren Financial Advisors Inc. raised its holdings in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on CME shares. JPMorgan Chase & Co. boosted their price objective on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Piper Sandler reaffirmed an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a report on Tuesday, August 20th. Bank of America downgraded CME Group from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $209.73.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $213.16 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The company has a market cap of $76.75 billion, a PE ratio of 24.25, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The company has a 50 day moving average of $207.86 and a 200-day moving average of $207.45. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $223.80.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter last year, the business posted $2.30 EPS. The company’s revenue was up 12.7% compared to the same quarter last year. As a group, equities research analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.16%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.